September 2, 2017 – The American Food & Drug Administration (FDA) has announced that two clinical trials with Pembrolizumab (Keytruda) in patients with multiple myeloma have been put on hold. The FDA informs the public, health care professionals, and oncology …

Pembrolizumab (Keytruda): Clinical trials on hold Read more »

April 05, 2010 – A very recent article by msnbc.com indicates that thalidomide, a drug that caused birth defects when it was launched as a morning sickness pill half a century ago, may be useful for treating a hereditary condition …

Thalidomide may fight blood vessel disorder: Nosebleeds eased with once-maligned drug Read more »